Literature DB >> 7576992

ApcMin: a mouse model for intestinal and mammary tumorigenesis.

A R Moser1, C Luongo, K A Gould, M K McNeley, A R Shoemaker, W F Dove.   

Abstract

Min (multiple intestinal neoplasia) is a mutant allele of the murine Apc (adenomatous polyposis coli) locus, encoding a nonsense mutation at codon 850. Like humans with germline mutations in APC, Min/+ mice are predisposed to intestinal adenoma formation. The number of adenomas is influenced by modifier loci carried by different inbred strains. One modifier locus, Mom-1 (modifier of Min-1), maps to distal chromosome 4. Intestinal tumours from both B6 (C57BL/6J) and hybrid Min/+ mice show extensive loss of the wild-type allele at Apc. B6 Min/+ female mice are predisposed to spontaneous mammary tumours. The incidence of both intestinal and mammary tumours can be increased in an age-specific manner by treatment with ethylnitrosourea (ENU). Min mice provide a good animal model for studying the role of Apc and interacting genes in the initiation and progression of intestinal and mammary tumorigenesis.

Entities:  

Mesh:

Year:  1995        PMID: 7576992     DOI: 10.1016/0959-8049(95)00181-h

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  100 in total

1.  Detection of Premalignant Gastrointestinal Lesions Using Surface-Enhanced Resonance Raman Scattering-Nanoparticle Endoscopy.

Authors:  Stefan Harmsen; Stephan Rogalla; Ruimin Huang; Massimiliano Spaliviero; Volker Neuschmelting; Yoku Hayakawa; Yoomi Lee; Yagnesh Tailor; Ricardo Toledo-Crow; Jeon Woong Kang; Jason M Samii; Hazem Karabeber; Ryan M Davis; Julie R White; Matt van de Rijn; Sanjiv S Gambhir; Christopher H Contag; Timothy C Wang; Moritz F Kircher
Journal:  ACS Nano       Date:  2019-02-04       Impact factor: 15.881

2.  Anti-cancer activity of nitrones in the Apc(Min/+) model of colorectal cancer.

Authors:  Robert A Floyd; Rheal A Towner; Dee Wu; Andrew Abbott; Rebecca Cranford; Dan Branch; Wei-Xing Guo; Steven B Foster; Inna Jones; Rajib Alam; Danny Moore; Toby Allen; Mark Huycke
Journal:  Free Radic Res       Date:  2010-01

3.  Heterozygosity of Chaperone Grp78 Reduces Intestinal Stem Cell Regeneration Potential and Protects against Adenoma Formation.

Authors:  Jooske F van Lidth de Jeude; Claudia N Spaan; Bartolomeus J Meijer; Wouter L Smit; Tanya T D Soeratram; Mattheus C B Wielenga; B Florien Westendorp; Amy S Lee; Sander Meisner; Jacqueline L M Vermeulen; Manon E Wildenberg; Gijs R van den Brink; Vanesa Muncan; Jarom Heijmans
Journal:  Cancer Res       Date:  2018-09-19       Impact factor: 12.701

4.  Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis.

Authors:  Melania Dovizio; Stefania Tacconelli; Emanuela Ricciotti; Annalisa Bruno; Thorsten Jürgen Maier; Paola Anzellotti; Luigia Di Francesco; Paola Sala; Stefano Signoroni; Lucio Bertario; Dan A Dixon; John A Lawson; Dieter Steinhilber; Garret A FitzGerald; Paola Patrignani
Journal:  J Pharmacol Exp Ther       Date:  2012-01-19       Impact factor: 4.030

5.  Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.

Authors:  Angela J Glading; Mark H Ginsberg
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

6.  Colonoscopy as a tool for evaluating colorectal tumor development in a mouse model.

Authors:  Tomohiro Adachi; Takao Hinoi; Yuu Sasaki; Hiroaki Niitsu; Yasuhumi Saito; Masashi Miguchi; Manabu Shimomura; Hideki Ohdan
Journal:  Int J Colorectal Dis       Date:  2013-11-09       Impact factor: 2.571

7.  Differential in vivo mechanism of chemoprevention of tumor formation in azoxymethane/dextran sodium sulfate mice by PEITC and DBM.

Authors:  Ka Lung Cheung; Tin Oo Khor; Mou-Tuan Huang; Ah-Ng Kong
Journal:  Carcinogenesis       Date:  2009-12-03       Impact factor: 4.944

8.  Heart Disease and Cancer: Are the Two Killers Colluding?

Authors:  Richard N Kitsis; Jaime A Riquelme; Sergio Lavandero
Journal:  Circulation       Date:  2018-08-14       Impact factor: 29.690

9.  Distinguishing between cancer driver and passenger gene alteration candidates via cross-species comparison: a pilot study.

Authors:  Xinglai Ji; Jie Tang; Richard Halberg; Dana Busam; Steve Ferriera; Maria Marjorette O Peña; Chinnambally Venkataramu; Timothy J Yeatman; Shaying Zhao
Journal:  BMC Cancer       Date:  2010-08-13       Impact factor: 4.430

10.  A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].

Authors:  Katayoon H Emami; Cu Nguyen; Hong Ma; Dae Hoon Kim; Kwang Won Jeong; Masakatsu Eguchi; Randall T Moon; Jia-Ling Teo; Se Woong Oh; Hak Yeop Kim; Sung Hwan Moon; Jong Ryul Ha; Michael Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.